TRV GP II, LLC's Net Worth

$600 Million

Estimate Recalculated Feb 15, 2024 05:05PM EST

Who is TRV GP II, LLC?

TRV GP II, LLC has an estimated net worth of $600 Million. This is based on reported shares across multiple companies, which include Revolution Medicines, Inc., Jounce Therapeutics, Inc., Blueprint Medicines Corp, Global Blood Therapeutics, Inc., Sage Therapeutics, Inc., MyoKardia Inc, and Allena Pharmaceuticals, Inc..

SEC CIK

TRV GP II, LLC's CIK is 0001614073

Past Insider Trading and Trends

2015 was TRV GP II, LLC's most active year for acquiring shares with 21 total transactions. TRV GP II, LLC's most active month to acquire stocks was the month of October. 2017 was TRV GP II, LLC's most active year for disposing of shares, totalling 25 transactions. TRV GP II, LLC's most active month to dispose stocks was the month of October. 2017 saw TRV GP II, LLC paying a total of $3,010,000.00 for 15,528,088 shares, this is the most they've acquired in one year. In 2021 TRV GP II, LLC cashed out on 8,411,837 shares for a total of $79,628,830.60, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Revolution Medicines, Inc. (RVMD) Snapshot price: $29.82

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-543.11K
$30.21
-$16,406,962.48
0
Jun 3 - Jun 4
Form 4
-71.55%
-1.37M
$30.57
-$41,764,208.12
543.11K
May 25 - May 26
Form 4
+2,560.14%
10.52M
10.93M
Feb 18
Form 3
0
0
No matching records found

Jounce Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-39.35%
-1.75M
2.7M
Scheduled
Sep 15
Form 4
-25.22%
-1.50M
4.45M
Scheduled
Jun 10
Form 4
-8.50%
-552.52K
$8.00
-$4,420,160.00
5.95M
May 25
Form 4
-16.13%
-1.25M
6.5M
Scheduled
Mar 11
Form 4
-15.76%
-1.45M
$11.75
-$17,037,500.00
7.75M
Mar 1
Form 4
-0.16%
-15.00K
$7.01
-$105,075.00
9.2M
Nov 19
Form 4
-0.16%
-15.00K
$7.25
-$108,772.50
9.22M
Nov 17
Form 4
-9.77%
-1.00M
9.23M
Nov 11
Form 4
+2,350.00%
12.74M
13.28M
Feb 1
Form 3
0
0
No matching records found

Blueprint Medicines Corp (BPMC) Snapshot price: $77.17

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.45%
-1.00M
3.45M
Scheduled
Feb 27
Form 4
-18.34%
-1.00M
$35.28
-$35,275,000.00
4.45M
Feb 7
Form 4
-18.03%
-1.20M
5.45M
Apr 14
Form 4
-8.37%
-618.44K
6.77M
Nov 18
Form 4
+2,610.79%
7.12M
7.39M
May 5
Form 3
0
0
No matching records found

Global Blood Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-28.78%
-1.00M
2.48M
Scheduled
Jun 14
Form 4
-22.42%
-1.05M
3.64M
Scheduled
Apr 11 - May 17
Form 4
-30.89%
-2.00M
4.48M
Scheduled
Apr 6
Form 4
-22.85%
-2.05M
$26.17
-$52,245,475.97
6.91M
Mar 2
Form 4
-21.11%
-2.00M
7.48M
Scheduled
Dec 14
Form 4
-15.67%
-2.00M
$19.36
-$38,720,000.00
10.76M
Nov 14
Form 4
-16.03%
-2.00M
10.48M
Nov 3
Form 4
+2,083.16%
11.9M
12.48M
Aug 17
Form 3
0
0
No matching records found

Sage Therapeutics, Inc. (SAGE) Snapshot price: $23.965

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-25.69%
-1.00M
2.89M
Aug 19
Form 4
-17.92%
-850.00K
$31.25
-$26,562,500.00
3.89M
May 16
Form 4
-25.50%
-1.67M
4.87M
Nov 12
Form 4
-25.90%
-2.29M
6.54M
Aug 18
Form 4
-10.00%
-981.20K
8.83M
Jun 19
Form 4
-11.38%
-1.26M
9.77M
Jan 27
Form 4
-5.59%
-652.76K
11.03M
Jan 16
Form 4
+2,353.02%
11.2M
11.68M
Jul 23
Form 3
0
0
No matching records found